How are Sumatriptan adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Sumatriptan, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Sumatriptan is flagged as the suspect drug causing the adverse event.
What are the most common Sumatriptan adverse events reported to the FDA?
Drug Ineffective | 2451 (13.54%) |
Product Quality Issue | 671 (3.71%) |
Nausea | 529 (2.92%) |
Headache | 480 (2.65%) |
Migraine | 395 (2.18%) |
Vomiting | 326 (1.8%) |
Chest Pain | 275 (1.52%) |
Chest Discomfort | 248 (1.37%) |
Device Malfunction | 236 (1.3%) |
Dizziness | 200 (1.1%) |
Dyspnoea | 199 (1.1%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Sumatriptan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sumatriptan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Sumatriptan adverse events reported to the FDA?
Therapeutic And Nontherapeutic Effe... | 3114 (17.2%) |
Neurological | 1212 (6.7%) |
Gastrointestinal Signs | 1115 (6.16%) |
Headaches | 907 (5.01%) |
Product Quality Issues | 804 (4.44%) |
Medication Errors | 604 (3.34%) |
Administration Site Reactions | 547 (3.02%) |
Respiratory | 532 (2.94%) |
Epidermal And Dermal Conditions | 319 (1.76%) |
Cardiac And Vascular Investigations | 296 (1.64%) |
Procedural And Device Related Injur... | 296 (1.64%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Sumatriptan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sumatriptan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Sumatriptan, according to those reporting adverse events to the FDA?
Migraine | 6565 |
Drug Use For Unknown Indication | 948 |
Headache | 481 |
Product Used For Unknown Indication | 293 |
Cluster Headache | 104 |
Ill-defined Disorder | 60 |
Show More |
Label | Labeler | Effective |
---|---|---|
Sumatriptan Succinate | SUN PHARMACEUTICAL INDUSTRIES LIMITED | 12-AUG-09 |
Sumatriptan Succinate | JHP Pharmaceuticals LLC | 04-SEP-09 |
Sumatriptan Succinate | Hikma Pharmaceutical | 28-SEP-09 |
Sumatriptan Succinate | Stat Rx USA | 27-OCT-09 |
Sumatriptan Succinate | Teva Parenteral Medicines, Inc | 28-OCT-09 |
Sumatriptan Succinate | Bedford Laboratories | 10-FEB-10 |
Sumatriptan Succinate | Dispensing Solutions Inc. | 03-MAR-10 |
Sumatriptan Succinate | Bedford Laboratories | 19-MAR-10 |
Sumatriptan Succinate | Physicians Total Care, Inc. | 24-MAY-10 |
Alsuma | US WorldMeds, LLC | 21-JUN-10 |
Sumatriptan Succinate | MedVantx, Inc. | 22-SEP-10 |
Sumatriptan Succinate | Rebel Distributors Corp | 01-DEC-10 |
Imitrex | Rebel Distributors Corp | 28-DEC-10 |
Sumatriptan Succinate | APP Pharmaceuticals, LLC | 12-APR-11 |
Sumavel Dosepro | Zogenix, Inc. | 01-JUN-11 |
Sumatriptan Succinate | Preferred Pharmaceuticals, Inc | 08-JUN-11 |
Treximet | Rebel Distributors Corp | 13-SEP-11 |
Sumatriptan Succinate | Par Pharmaceutical Inc | 28-NOV-11 |
Imitrex | Physicians Total Care, Inc. | 12-DEC-11 |
Sumatriptan | Physicians Total Care, Inc. | 12-DEC-11 |
Sumatriptan Succinate | H.J. Harkins Company, Inc. | 29-DEC-11 |
Sumatriptan Succinate | Wockhardt USA LLC. | 15-FEB-12 |
Sumatriptan Succinate | Wockhardt Limited | 05-MAR-12 |
Imitrex | GlaxoSmithKline LLC | 26-MAR-12 |
Imitrex | GlaxoSmithKline LLC | 27-MAR-12 |
Sumatriptan Succinate | Dr. Reddy's Laboratories Limited | 30-MAR-12 |
Sumatriptan Succinate | Unit Dose Services | 30-MAR-12 |
Sumatriptan | Ranbaxy Pharmaceuticals Inc. | 01-MAY-12 |
Imitrex | Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | 02-MAY-12 |
Sumatriptan Succinate | Rebel Distributors Corp | 08-MAY-12 |
Sumatriptan | Sandoz Inc | 09-MAY-12 |
Sumatriptan | Aurobindo Pharma Limited | 11-MAY-12 |
Sumatriptan | Preferred Pharmaceuticals, Inc. | 04-JUN-12 |
Sumatriptan Succinate | American Health Packaging | 19-JUL-12 |
Sumatriptan Succinate | Teva Pharmaceuticals USA Inc | 30-JUL-12 |
Sumatriptan Succinate | Sun Pharma Global FZE | 13-AUG-12 |
Sumatriptan Succinate | Lake Erie Medical DBA Quality Care Products LLC | 30-AUG-12 |
Sumatriptan | Northstar Rx LLC | 17-SEP-12 |
Sumatriptan Succinate | Mylan Pharmaceuticals Inc. | 28-SEP-12 |
Imitrex | GlaxoSmithKline LLC | 02-OCT-12 |
Sumatriptan | Greenstone LLC | 10-OCT-12 |
Sumatriptan Succinate | STAT Rx USA LLC | 11-OCT-12 |
Treximet | GlaxoSmithKline LLC | 07-NOV-12 |
Sumatriptan Succinate | Cobalt Laboratories | 17-DEC-12 |
Alsuma | Pfizer Laboratories Div Pfizer Inc | 20-DEC-12 |
Sumatriptan Succinate | Sagent Pharmaceuticals | 31-DEC-12 |
Sumatriptan Succinate | Sandoz Inc | 31-JAN-13 |
Sumatriptan Succinate | Teva Pharmaceuticals USA Inc | 22-APR-13 |
Sumatriptan | AuroMedics Pharma LLC | 29-APR-13 |
What Sumatriptan safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Sumatriptan. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Sumatriptan.